A small number of therapeutic communities have been established in the United Kingdom, the United States, and Switzerland to discover whether young people with first or second admissions suffering from acute schizophrenia or schizophreniform psychosis could be effectively treated in small family-like settings with the minimal use of neuroleptics. Two studies using controls treated in conventional settings demonstrated comparable or better outcome on a number of indices in the therapeutic community samples. Reliance on medication at follow-up was significantly lower, although there were no cost savings.(2 26) A 20-year study of an acute psychiatric ward in Finland found that acute psychotic and borderline patients seemed to benefit from the therapeutic community model with a high level of support, negotiation, order, and organization.(27)
Was this article helpful?